Precision Immunotherapy:

The Need for Speed

EpiVax Oncology developed a game-changing neoantigen personalized cancer vaccine proprietary process with an accelerated biopsy-to-needle

timeline of under 4 weeks 

© Copyright Epivax Oncology 2020